Tumor-specific usage of alternative transcription start sites in colorectal cancer identified by genome-wide exon array analysis

BackgroundApproximately half of all human genes use alternative transcription start sites (TSSs) to control mRNA levels and broaden the transcriptional output in healthy tissues. Aberrant expression patterns promoting carcinogenesis, however, may arise from alternative promoter usage.ResultsBy profiling 108 colorectal samples using exon arrays, we identified nine genes (TCF12, OSBPL1A, TRAK1, ANK3, CHEK1, UGP2, LMO7, ACSL5, and SCIN) showing tumor-specific alternative TSS usage in both adenoma and cancer samples relative to normal mucosa. Analysis of independent exon array data sets corroborated these findings. Additionally, we confirmed the observed patterns for selected mRNAs using quantitative real-time reverse-transcription PCR. Interestingly, for some of the genes, the tumor-specific TSS usage was not restricted to colorectal cancer. A comprehensive survey of the nine genes in lung, bladder, liver, prostate, gastric, and brain cancer revealed significantly altered mRNA isoform ratios for CHEK1, OSBPL1A, and TCF12 in a subset of these cancer types.To identify the mechanism responsible for the shift in alternative TSS usage, we antagonized the Wnt-signaling pathway in DLD1 and Ls174T colorectal cancer cell lines, which remarkably led to a shift in the preferred TSS for both OSBPL1A and TRAK1. This indicated a regulatory role of the Wnt pathway in selecting TSS, possibly also involving TP53 and SOX9, as their transcription binding sites were enriched in the promoters of the tumor preferred isoforms together with their mRNA levels being increased in tumor samples.Finally, to evaluate the prognostic impact of the altered TSS usage, immunohistochemistry was used to show deregulation of the total protein levels of both TCF12 and OSBPL1A, corresponding to the mRNA levels observed. Furthermore, the level of nuclear TCF12 had a significant correlation to progression free survival in a cohort of 248 stage II colorectal cancer samples.ConclusionsAlternative TSS usage in colorectal adenoma and cancer samples has been shown for nine genes, and OSBPL1A and TRAK1 were found to be regulated in vitro by Wnt signaling. TCF12 protein expression was upregulated in cancer samples and correlated with progression free survival.

[1]  Chun-Fang Xu,et al.  Distinct transcription start sites generate two forms of BRCA1 mRNA. , 1995, Human molecular genetics.

[2]  N. Blom,et al.  Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. , 1999, Journal of molecular biology.

[3]  Philipp Bucher,et al.  The Eukaryotic Promoter Database EPD: the impact of in silico primer extension , 2004, Nucleic Acids Res..

[4]  K. Nakai,et al.  Massive transcriptional start site analysis of human genes in hypoxia cells , 2009, Nucleic acids research.

[5]  J. Jass.  Classification of colorectal cancer based on correlation of clinical, morphological and molecular features , 2007, Histopathology.

[6]  P. Hainaut,et al.  p53 isoforms - A conspiracy to kidnap p53 tumor suppressor activity? , 2009, Cellular and Molecular Life Sciences.

[7]  Søren Brunak,et al.  Prediction of human protein function according to Gene Ontology categories , 2003, Bioinform..

[8]  Daehyun Baek,et al.  Characterization and predictive discovery of evolutionarily conserved mammalian alternative promoters. , 2007, Genome research.

[9]  S. Hirohashi,et al.  Involvement of splicing factor-1 in beta-catenin/T-cell factor-4-mediated gene transactivation and pre-mRNA splicing. , 2007, Gastroenterology.

[10]  Hans Clevers,et al.  Genome-Wide Pattern of TCF7L2/TCF4 Chromatin Occupancy in Colorectal Cancer Cells , 2008, Molecular and Cellular Biology.

[11]  Martin S. Taylor,et al.  Genome-wide analysis of mammalian promoter architecture and evolution , 2006, Nature Genetics.

[12]  Liam J. McGuffin,et al.  Protein structure prediction servers at University College London , 2005, Nucleic Acids Res..

[13]  T. Ørntoft,et al.  Dysregulation of the transcription factors SOX4, CBFB and SMARCC1 correlates with outcome of colorectal cancer , 2009, British Journal of Cancer.

[14]  Tyson A. Clark,et al.  Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array , 2006, BMC Genomics.

[15]  S. Hirohashi,et al.  Combined Functional Genome Survey of Therapeutic Targets for Hepatocellular Carcinoma , 2010, Clinical Cancer Research.

[16]  T. Ørntoft,et al.  Gene expression signatures for colorectal cancer microsatellite status and HNPCC , 2005, British Journal of Cancer.

[17]  Tom H. Pringle,et al.  The human genome browser at UCSC. , 2002, Genome research.

[18]  Kenta Nakai,et al.  Genome-wide characterization of transcriptional start sites in humans by integrative transcriptome analysis. , 2011, Genome research.

[19]  Ernesto Picardi,et al.  UTRdb and UTRsite (RELEASE 2010): a collection of sequences and regulatory motifs of the untranslated regions of eukaryotic mRNAs , 2009, Nucleic Acids Res..

[20]  M. Bushell,et al.  TOPs and their regulation. , 2006, Biochemical Society transactions.

[21]  S. Brunak,et al.  Improved prediction of signal peptides: SignalP 3.0. , 2004, Journal of molecular biology.

[22]  Sumio Sugano,et al.  The functional consequences of alternative promoter use in mammalian genomes. , 2008, Trends in genetics : TIG.

[23]  L. Holm,et al.  The Pfam protein families database , 2005, Nucleic Acids Res..

[24]  Y. Asmann,et al.  A Transposon-Based Genetic Screen in Mice Identifies Genes Altered in Colorectal Cancer , 2009, Science.

[25]  Hans Clevers,et al.  SOX9 is an intestine crypt transcription factor, is regulated by the Wnt pathway, and represses the CDX2 and MUC2 genes , 2004, The Journal of cell biology.

[26]  P. Leder,et al.  The human c-myc oncogene: Structural consequences of translocation into the igh locus in Burkitt lymphoma , 1983, Cell.

[27]  Søren Brunak,et al.  Analysis and prediction of leucine-rich nuclear export signals. , 2004, Protein engineering, design & selection : PEDS.

[28]  S. Brunak,et al.  Prediction, conservation analysis, and structural characterization of mammalian mucin-type O-glycosylation sites. , 2005, Glycobiology.

[29]  Adrian R. Krainer,et al.  Alternative Splicing of SLC39A14 in Colorectal Cancer is Regulated by the Wnt Pathway* , 2010, Molecular & Cellular Proteomics.

[30]  H. Clevers,et al.  The Intestinal Wnt/TCF Signature. , 2007, Gastroenterology.

[31]  T. Godfrey,et al.  Whole genome exon arrays identify differential expression of alternatively spliced, cancer-related genes in lung cancer , 2008, Nucleic acids research.

[32]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[33]  M. J. van den Bent,et al.  Identification of differentially regulated splice variants and novel exons in glial brain tumors using exon expression arrays. , 2007, Cancer research.

[34]  K. Nakai,et al.  Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes. , 2005, Genome research.

[35]  Hans Clevers,et al.  The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. , 2002, Cell.

[36]  H. Clevers,et al.  Linking Colorectal Cancer to Wnt Signaling , 2000, Cell.

[37]  Bart De Moor,et al.  TOUCAN 2: the all-inclusive open source workbench for regulatory sequence analysis , 2005, Nucleic Acids Res..

[38]  Claus Lindbjerg Andersen,et al.  Normalization of Real-Time Quantitative Reverse Transcription-PCR Data: A Model-Based Variance Estimation Approach to Identify Genes Suited for Normalization, Applied to Bladder and Colon Cancer Data Sets , 2004, Cancer Research.

[39]  Anne-Mette K. Hein,et al.  Alternative Splicing in Colon, Bladder, and Prostate Cancer Identified by Exon Array Analysis*S , 2008, Molecular & Cellular Proteomics.

[40]  Hsien-Da Huang,et al.  RegRNA: an integrated web server for identifying regulatory RNA motifs and elements , 2006, Nucleic Acids Res..

[41]  Martin J. Aryee,et al.  Chromosome-wide mapping of DNA methylation patterns in normal and malignant prostate cells reveals pervasive methylation of gene-associated and conserved intergenic sequences , 2011, BMC Genomics.

[42]  C. Sander,et al.  Integrative genomic profiling of human prostate cancer. , 2010, Cancer cell.

[43]  M. Sigvardsson,et al.  Context-Dependent Regulation of Hematopoietic Lineage Choice by HEBAlt , 2010, The Journal of Immunology.

[44]  E. Rothenberg,et al.  The Basic Helix-Loop-Helix Transcription Factor HEBAlt Is Expressed in Pro-T Cells and Enhances the Generation of T Cell Precursors1 , 2006, The Journal of Immunology.

[45]  Rasmus Wernersson,et al.  FeatureMap3D—a tool to map protein features and sequence conservation onto homologous structures in the PDB , 2006, Nucleic Acids Res..

[46]  K. Nakai,et al.  Diverse DNA methylation statuses at alternative promoters of human genes in various tissues. , 2006, DNA research : an international journal for rapid publication of reports on genes and genomes.

[47]  S. Brunak,et al.  Locating proteins in the cell using TargetP, SignalP and related tools , 2007, Nature Protocols.

[48]  S. Kato,et al.  Construction of a human full-length cDNA bank. , 1994, Gene.

[49]  H Clevers,et al.  Extensive alternative splicing and dual promoter usage generate Tcf-1 protein isoforms with differential transcription control properties , 1996, Molecular and cellular biology.

[50]  Y. Nie,et al.  Elevated expression of MGb2-Ag/TRAK1 is correlated with poor prognosis in patients with colorectal cancer , 2011, International Journal of Colorectal Disease.